-+ 0.00%
-+ 0.00%
-+ 0.00%

KRYSTAL BIOTECH TO ANNOUNCE INTERIM CLINICAL UPDATE FROM HIGHEST DOSE COHORT OF PHASE 1 CORAL-1 STUDY EVALUATING KB407 IN PATIENTS WITH CYSTIC FIBROSIS

路透·01/07/2026 21:05:01

登錄查看新聞詳情